Index S&P 500
P/E 25.19
EPS (ttm) 4.44
Insider Own 0.19%
Shs Outstand 199.10M
Perf Week 3.91%
Market Cap 22.25B
Forward P/E 12.63
EPS next Y 8.85
Insider Trans -0.38%
Shs Float 198.69M
Perf Month 8.17%
Income 903.70M
PEG 4.06
EPS next Q 1.77
Inst Own 92.86%
Short Float 3.55%
Perf Quarter 4.61%
Sales 7.68B
P/S 2.90
EPS this Y 2.53%
Inst Trans 0.14%
Short Ratio 3.83
Perf Half Y 5.21%
Book/sh 62.62
P/B 1.78
EPS next Y 7.87%
ROA 4.22%
Short Interest 7.05M
Perf Year -11.26%
Cash/sh 2.64
P/C 42.34
EPS next 5Y 6.21%
ROE 7.24%
52W Range 97.69 - 133.90
Perf YTD 5.82%
Dividend Est. 0.89 (0.80%)
P/FCF 21.09
EPS past 5Y -4.13%
ROI 5.02%
52W High -16.52%
Beta 0.87
Dividend TTM 0.96 (0.86%)
Quick Ratio 0.99
Sales past 5Y -0.55%
Gross Margin 61.27%
52W Low 14.42%
ATR (14) 2.79
Dividend Ex-Date Mar 31, 2025
Current Ratio 1.91
EPS Y/Y TTM -9.29%
Oper. Margin 17.88%
RSI (14) 60.27
Volatility 2.53% 2.59%
Employees 17000
Debt/Eq 0.51
Sales Y/Y TTM 3.84%
Profit Margin 11.77%
Recom 2.47
Target Price 120.00
Option/Short Yes / Yes
LT Debt/Eq 0.44
EPS Q/Q -40.41%
Payout 21.66%
Rel Volume 0.76
Prev Close 112.91
Sales Surprise 0.44%
EPS Surprise 0.64%
Sales Q/Q 4.28%
Earnings Feb 06 BMO
Avg Volume 1.84M
Price 111.78
SMA20 4.09%
SMA50 4.94%
SMA200 3.65%
Trades
Volume 1,431,492
Change -1.00%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-17-24 Upgrade
JP Morgan
Neutral → Overweight
$125 → $128
Sep-10-24 Initiated
Wolfe Research
Peer Perform
Jul-01-24 Downgrade
Piper Sandler
Overweight → Neutral
$140 → $115
May-30-24 Initiated
Goldman
Neutral
$129
May-21-24 Upgrade
Argus
Hold → Buy
$150
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated
ROTH MKM
Neutral
$120
Aug-28-23 Upgrade
BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade
BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade
Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade
Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated
UBS
Sell
$112
Mar-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade
Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade
Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated
Barclays
Underweight
$104
Oct-12-22 Initiated
Jefferies
Underperform
$95
May-27-22 Downgrade
Needham
Buy → Hold
Show Previous Ratings
Mar-11-25 04:01PM
Mar-10-25 08:05PM
08:37AM
07:30AM
Mar-07-25 07:30AM
07:30AM
Loading…
Mar-06-25 07:30AM
Mar-05-25 09:18AM
Feb-28-25 07:30AM
Feb-27-25 07:30AM
Feb-26-25 12:40PM
07:30AM
07:00AM
Feb-25-25 04:05PM
Feb-13-25 03:27AM
(Thomson Reuters StreetEvents)
02:10AM
07:37PM
Loading…
Feb-10-25 07:37PM
Feb-07-25 02:50PM
02:11AM
02:04AM
12:36AM
(Thomson Reuters StreetEvents)
Feb-06-25 01:10PM
09:30AM
08:41AM
07:40AM
06:47AM
06:47AM
06:39AM
(Associated Press Finance)
06:30AM
Feb-05-25 08:12AM
Feb-04-25 09:15AM
10:21AM
Loading…
Jan-29-25 10:21AM
10:01AM
06:52AM
06:42AM
Jan-28-25 06:11PM
05:59PM
Jan-20-25 11:16AM
Jan-16-25 07:30AM
Jan-15-25 11:58AM
08:34AM
Jan-03-25 06:50AM
Dec-27-24 10:24AM
Dec-20-24 07:30AM
Dec-19-24 07:36AM
Dec-18-24 12:00PM
07:00AM
02:09AM
(Thomson Reuters StreetEvents)
Dec-17-24 09:36AM
Dec-16-24 07:13AM
06:13AM
Dec-13-24 07:30AM
Dec-10-24 11:14PM
Dec-05-24 08:52AM
07:36AM
Dec-04-24 07:30AM
Nov-29-24 11:32AM
Nov-26-24 01:54AM
Nov-25-24 04:05PM
Nov-21-24 07:30AM
Nov-18-24 07:30AM
Nov-16-24 10:11AM
Nov-13-24 07:30AM
Nov-07-24 07:30AM
Nov-04-24 08:19AM
06:14AM
Oct-31-24 07:19PM
03:10AM
(Thomson Reuters StreetEvents)
03:06AM
Oct-30-24 09:30AM
07:53AM
07:40AM
06:36AM
(Associated Press Finance)
06:30AM
Oct-29-24 09:15AM
Oct-28-24 04:34PM
07:30AM
Oct-25-24 03:05AM
Oct-23-24 10:01AM
Oct-16-24 07:35AM
Oct-09-24 07:30AM
Sep-18-24 07:06AM
Sep-06-24 11:31AM
Sep-05-24 05:16PM
04:04PM
(Investor's Business Daily)
03:59PM
03:29PM
11:37AM
07:30AM
Aug-29-24 04:43PM
Aug-21-24 07:30AM
Aug-15-24 09:02AM
Aug-12-24 08:53AM
Aug-09-24 06:54AM
01:12AM
Aug-08-24 09:40AM
06:32AM
Aug-07-24 05:01PM
12:13PM
09:30AM
07:44AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '25 Option Exercise 0.00 2,094 0 60,862 Mar 07 05:53 PM Bezjak Mark President, Americas Mar 06 '25 Option Exercise 0.00 1,621 0 13,772 Mar 07 05:39 PM Stellato Paul A VP, Controller & CAO Mar 06 '25 Option Exercise 0.00 608 0 2,534 Mar 07 05:38 PM Winkler Lori SVP and CHRO Mar 06 '25 Option Exercise 0.00 1,757 0 10,525 Mar 07 05:37 PM Winkler Lori SVP and CHRO Mar 05 '25 Sale 104.40 1,443 150,649 8,768 Mar 07 05:37 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '25 Option Exercise 0.00 2,162 0 20,103 Mar 07 05:36 PM Tornos Ivan President & CEO Mar 06 '25 Option Exercise 0.00 10,268 0 57,432 Mar 07 05:35 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '25 Option Exercise 0.00 4,560 0 50,882 Mar 07 05:34 PM Yi Sang Group President, Asia Pacific Mar 06 '25 Option Exercise 0.00 2,365 0 21,424 Mar 07 05:32 PM Winkler Lori Officer Mar 05 '25 Proposed Sale 104.40 1,443 150,653 Mar 05 03:02 PM Bezjak Mark President, Americas Feb 20 '25 Option Exercise 0.00 2,519 0 12,845 Feb 24 04:15 PM Winkler Lori SVP and CHRO Feb 20 '25 Option Exercise 0.00 1,907 0 10,676 Feb 24 04:14 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 20 '25 Option Exercise 0.00 2,247 0 59,653 Feb 24 04:12 PM Ellingson Rachel Chief Administrative Officer Feb 20 '25 Option Exercise 0.00 1,566 0 12,397 Feb 24 04:11 PM Stellato Paul A VP, Controller & CAO Feb 20 '25 Option Exercise 0.00 702 0 2,184 Feb 24 04:10 PM Tornos Ivan President and CEO Feb 20 '25 Option Exercise 0.00 15,996 0 56,010 Feb 24 04:09 PM Upadhyay Suketu Exec. VP, CFO Feb 20 '25 Option Exercise 0.00 5,446 0 48,745 Feb 24 04:08 PM VAN ZUILEN WILFRED Group Pres, EMEA Feb 20 '25 Option Exercise 0.00 2,451 0 18,586 Feb 24 04:07 PM Yi Sang Group President, Asia Pacific Feb 20 '25 Option Exercise 0.00 2,383 0 19,059 Feb 24 04:05 PM Yi Sang Group President, Asia Pacific Feb 18 '25 Option Exercise 0.00 11,138 0 16,676 Feb 19 06:03 PM Winkler Lori SVP and CHRO Feb 18 '25 Option Exercise 0.00 7,208 0 10,571 Feb 19 06:02 PM VAN ZUILEN WILFRED Group Pres, EMEA Feb 18 '25 Option Exercise 0.00 9,174 0 18,549 Feb 19 06:01 PM Tornos Ivan President and CEO Feb 18 '25 Option Exercise 0.00 25,878 0 52,840 Feb 19 06:00 PM Upadhyay Suketu Exec. VP, CFO Feb 18 '25 Option Exercise 0.00 21,622 0 51,454 Feb 19 05:59 PM Bezjak Mark President, Americas Feb 18 '25 Option Exercise 0.00 7,865 0 12,280 Feb 19 05:57 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 18 '25 Option Exercise 0.00 10,158 0 59,958 Feb 19 05:57 PM Ellingson Rachel Chief Administrative Officer Feb 18 '25 Option Exercise 0.00 5,572 0 12,623 Feb 19 05:56 PM Upadhyay Suketu Exec. VP, CFO Nov 10 '24 Option Exercise 0.00 15,948 0 36,842 Nov 12 04:32 PM VAN ZUILEN WILFRED Group Pres, EMEA Jul 01 '24 Option Exercise 0.00 2,633 0 9,800 Jul 03 04:23 PM Yi Sang Group President, Asia Pacific May 31 '24 Sale 114.69 12,857 1,474,582 5,322 Jun 04 04:21 PM Stellato Paul A VP, Controller & CAO Jun 01 '24 Option Exercise 0.00 627 0 1,579 Jun 04 04:20 PM Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite